|
Lixil Corporation (5938.T) Évaluation DCF |
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
LIXIL Corporation (5938.T) Bundle
Rationalisez votre analyse et améliorez la précision avec notre (5938T) Calculator DCF! En utilisant des données Real Lixil Corporation et des hypothèses personnalisables, cet outil vous permet de prévoir, analyser et valoriser le lixil comme un investisseur chevronné.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,694,439.0 | 1,378,255.0 | 1,428,578.0 | 1,495,987.0 | 1,483,224.0 | 1,441,903.5 | 1,401,734.1 | 1,362,683.8 | 1,324,721.4 | 1,287,816.5 |
| Revenue Growth, % | 0 | -18.66 | 3.65 | 4.72 | -0.85315 | -2.79 | -2.79 | -2.79 | -2.79 | -2.79 |
| EBITDA | 149,985.0 | 121,399.0 | 152,431.0 | 107,175.0 | 101,189.0 | 122,032.0 | 118,632.4 | 115,327.4 | 112,114.6 | 108,991.2 |
| EBITDA, % | 8.85 | 8.81 | 10.67 | 7.16 | 6.82 | 8.46 | 8.46 | 8.46 | 8.46 | 8.46 |
| Depreciation | 105,135.0 | 83,928.0 | 80,541.0 | 81,767.0 | 81,330.0 | 83,287.4 | 80,967.2 | 78,711.5 | 76,518.8 | 74,387.0 |
| Depreciation, % | 6.2 | 6.09 | 5.64 | 5.47 | 5.48 | 5.78 | 5.78 | 5.78 | 5.78 | 5.78 |
| EBIT | 44,850.0 | 37,471.0 | 71,890.0 | 25,408.0 | 19,859.0 | 38,744.6 | 37,665.2 | 36,615.9 | 35,595.8 | 34,604.2 |
| EBIT, % | 2.65 | 2.72 | 5.03 | 1.7 | 1.34 | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 |
| Total Cash | 111,290.0 | 124,941.0 | 123,499.0 | 127,649.0 | 124,485.0 | 118,823.3 | 115,513.1 | 112,295.0 | 109,166.7 | 106,125.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 329,074.0 | 311,795.0 | 300,740.0 | 314,838.0 | 300,179.0 | 301,008.2 | 292,622.5 | 284,470.5 | 276,545.5 | 268,841.4 |
| Account Receivables, % | 19.42 | 22.62 | 21.05 | 21.05 | 20.24 | 20.88 | 20.88 | 20.88 | 20.88 | 20.88 |
| Inventories | 227,606.0 | 180,417.0 | 237,927.0 | 276,645.0 | 248,300.0 | 226,121.1 | 219,821.7 | 213,697.8 | 207,744.5 | 201,957.0 |
| Inventories, % | 13.43 | 13.09 | 16.65 | 18.49 | 16.74 | 15.68 | 15.68 | 15.68 | 15.68 | 15.68 |
| Accounts Payable | 208,044.0 | 173,622.0 | 214,378.0 | 205,262.0 | 248,800.0 | 202,953.1 | 197,299.1 | 191,802.6 | 186,459.3 | 181,264.8 |
| Accounts Payable, % | 12.28 | 12.6 | 15.01 | 13.72 | 16.77 | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 |
| Capital Expenditure | -68,635.0 | -68,498.0 | -48,634.0 | -55,349.0 | -52,873.0 | -56,780.5 | -55,198.7 | -53,661.0 | -52,166.0 | -50,712.8 |
| Capital Expenditure, % | -4.05 | -4.97 | -3.4 | -3.7 | -3.56 | -3.94 | -3.94 | -3.94 | -3.94 | -3.94 |
| Tax Rate, % | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 | 308.7 |
| EBITAT | 11,993.6 | 36,633.0 | 51,947.2 | 20,562.7 | -41,446.4 | 21,518.3 | 20,918.8 | 20,336.1 | 19,769.5 | 19,218.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -300,142.4 | 82,109.0 | 78,155.2 | -14,951.3 | 73,552.6 | 23,528.0 | 55,718.4 | 54,166.1 | 52,657.2 | 51,190.2 |
| WACC, % | 3.85 | 5.51 | 4.92 | 5.12 | 3.23 | 4.52 | 4.52 | 4.52 | 4.52 | 4.52 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 206,083.0 | |||||||||
| Long Term Growth Rate, % | 3.20 | |||||||||
| Free cash flow (T + 1) | 52,828 | |||||||||
| Terminal Value | 3,987,451 | |||||||||
| Present Terminal Value | 3,195,930 | |||||||||
| Enterprise Value | 3,402,013 | |||||||||
| Net Debt | 552,707 | |||||||||
| Equity Value | 2,849,306 | |||||||||
| Diluted Shares Outstanding, MM | 287 | |||||||||
| Equity Value Per Share | 9,923.03 |
What You Will Receive
- Customizable Excel Template: A comprehensive Excel-based DCF Calculator featuring pre-filled financials for LIXIL Corporation (5938T).
- Actual Data Insights: Access to historical performance and future estimates (displayed in the highlighted cells).
- Adjustable Forecasts: Modify key assumptions such as revenue growth, EBITDA percentage, and WACC.
- Instant Calculations: Quickly observe how your changes affect LIXIL's valuation.
- Professional-Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Interface: Developed for ease of use, with clear organization and detailed instructions.
Key Features
- Advanced DCF Calculator: Offers comprehensive unlevered and levered DCF valuation models tailored for LIXIL Corporation (5938T).
- WACC Calculator: Comes with a pre-configured Weighted Average Cost of Capital sheet featuring adjustable inputs.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios specifically for LIXIL Corporation (5938T).
- Interactive Dashboard and Charts: Visual representations provide a concise summary of key valuation metrics for straightforward analysis.
How It Operates
- 1. Access the Template: Download and open the Excel file containing LIXIL Corporation’s preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenses.
- 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV.
- 4. Experiment with Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Assurance: Showcase professional valuation findings to enhance your decision-making.
Why Select This Calculator?
- User-Friendly Interface: Tailored for both novices and experienced users.
- Customizable Inputs: Easily adjust parameters to suit your analysis needs.
- Real-Time Adjustments: Observe immediate updates to LIXIL’s valuation as you tweak inputs.
- Pre-Configured: Comes with LIXIL’s actual financial data for swift evaluations.
- Endorsed by Experts: Preferred by investors and analysts for making strategic decisions.
Who Can Benefit from This Product?
- Individual Investors: Make well-informed decisions regarding the purchase or sale of LIXIL Corporation (5938T) stock.
- Financial Analysts: Enhance valuation methodologies with ready-to-implement financial models tailored for LIXIL Corporation (5938T).
- Consultants: Provide accurate and timely valuation insights for clients around LIXIL Corporation (5938T).
- Business Owners: Gain insights into how major corporations like LIXIL Corporation (5938T) are valued to inform your own business strategies.
- Finance Students: Explore valuation techniques using real-world data and scenarios pertinent to LIXIL Corporation (5938T).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for LIXIL Corporation (5938T), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that display intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate thorough analysis.
- Key Ratios: A collection of profitability, leverage, and efficiency ratios pertinent to LIXIL Corporation (5938T).
- Dashboard and Charts: A visual representation of valuation outputs and assumptions for easy analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.